Fischer Medical Ventures Limited (FISCHER) — Board Meeting | 11 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approved conversion of 23 lakh warrants into equity shares.
🔄 What Changed
Added 23 lakh equity shares and Rs 4.0365 crore consideration from warrant conversion.
💡 Investor Takeaway
The conversion raises capital and increases shareholding for the promoter.

Fischer Medical Ventures Limited announced the board's approval on August 11, 2026, to convert 23 lakh convertible warrants into equity shares at Rs 23.40 per share, receiving Rs 4.0365 crore from the exercise price of Rs 17.55 per warrant, fully paid up.

📄 View Original Announcement (PDF)

About Fischer Medical Ventures Limited (FISCHER)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹2,261.37 Cr P/E: 59.0

View full FISCHER stock details →

📡 Get AI alerts when FISCHER files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FISCHER — Free

📊 More FISCHER filings

See all FISCHER filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FISCHER files new disclosures

Track FISCHER filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FISCHER — Free

Free account · 2 AI queries/day